The first drug to treat a lack of female sexual desire has been approved by federal authorities.
The drug flibanserin, which has been coined ‘female Viagra,’ is intended to treat women with a condition called hypoactive sexual desire disorder (HSDD) that’s characterized by lagging libido. On Tuesday, the drug was approved by the U.S. Food and Drug Administration. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.
The FDA hasn’t approved Viagra itself for women to use. But it has been prescribed off-label for women with a low sex drive. Evidence of its effectiveness is mixed at best.
There are several reasons that women would seek out a Viagra-like pill. As they approach middle age and beyond, it’s not uncommon for women to observe a decrease in their overall sex drive.
A second study discussed in the review found that both pre- and postmenopausal women reported no significant positive responses when using Viagra.
The FDA hasn’t approved Viagra itself for women to use. But it has been prescribed off-label for women with a low sex drive. Evidence of its effectiveness is mixed at best.
0 коммент.:
Отправить комментарий